4
Changes in Ownership
GeneDx Holdings Corp. Filed Acc 0001415889-25-016651
CHIEF FINANCIAL OFFICER sold 1,266 shares at $72.55 ($91,848)
- CHIEF FINANCIAL OFFICER acquired 2,462 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Feeley Kevin CHIEF FINANCIAL OFFICER | 2025-06-09 | Option exercise | +2,462 | 6,567 | D | ||
| Feeley Kevin CHIEF FINANCIAL OFFICER | 2025-06-09 | Sale | −1,266 | $72.55 | $91,848 | 5,301 | D |
| Derivatives | |||||||
| Feeley Kevin CHIEF FINANCIAL OFFICER | 2025-06-09 | Option exercise · Restricted Stock Unit | −2,462 | 14,773 | D | ||
| Open-market sales · 1,266 sh · avg $72.55 · $91,848 | |||||||
Loading xslF345X05/form4-06112025_080657.xml…